top of page
Understanding Your Options in Cancer Treatment
Axelopran is an experimental therapeutic agent developed by Glycyx. We are currently looking to begin a Phase 2b clinical study. Please consult your health care provider for additional information about participating in clinical studies.
Interested in Participating in a Clinical Trial?
If you or a loved one are considering participating in a clinical trial involving axelopran, please reach out to our Clinical Trials Department. Our team is ready to connect with a health care provider that can provide you with additional information about ongoing studies, eligibility criteria, and how you can apply.
"When you have exhausted all possibilities, remember this: You haven't."
Thomas Edison
bottom of page